The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus

One of the key features of chronic hepatitis B virus (HBV) infection is the inability to mount sufficient and coordinated adaptive immune responses against HBV. Recent studies on HBV-specific B cells and antibody to hepatitis B surface antigen (anti-HBs) have shed light on their role in the pathogen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ling Ding, Jiaquan Huang, Shuaiwen Huang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	Hepatitis B virus hepatitis B surface antibody functional cure HBV-specific B cells therapeutic vaccines
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2445283
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
by: Ya-Li Zhang, et al.
Published: (2019-01-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran
by: Amitis Ramezani, et al.
Published: (2010-10-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population
by: Moses P. Adoga, et al.
Published: (2010-08-01)

Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis
by: Yi-Jie Huang, et al.
Published: (2025-01-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Variety of the hepatitis B virus genovariants in the military
by: Yu. V. Ostankova, et al.
Published: (2019-10-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
by: O. I. Urazova, et al.
Published: (2014-07-01)

Hepatitis B virus and its sexually transmitted infection – an update
by: Takako Inoue, et al.
Published: (2016-09-01)

Hepatitis D virus antibodies and liver function profile among patients with chronic hepatitis B infection in Abuja, Nigeria
by: Lukman O Abdulkareem, et al.
Published: (2021-01-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Booster immunity – diagnosis of chronic hepatitis B viral infection
by: Radka T Komitova, et al.
Published: (2019-03-01)

Editorial: Chronic hepatitis B management: current status and future directions
by: Ivana Lazarevic, et al.
Published: (2025-06-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Some results of studying the effectiveness of vaccination against hepatitis B
by: L. V. Rubis
Published: (2020-06-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination
by: Anna D. Kosinska, et al.
Published: (2025-09-01)

Seroprevalence of hepatitis B among the general population in Shandong Province, Eastern China, an update 30 years after the implementation of the neonatal vaccination program
by: Bingyu Yan, et al.
Published: (2024-12-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Serum hepatitis B core antibody as the prognostic factor for diffuse large B-cell lymphoma
by: Yi Rong, et al.
Published: (2025-05-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Musculoskeletal adverse events reported post-hepatitis B vaccination in the vaccine adverse event reporting system
by: Yiqing Sun, et al.
Published: (2025-05-01)

Prevalence of Hepatitis B Core Antibodies and Occult Hepatitis B Infection among Blood Donors in Erbil Governorate, Iraq
by: Nza Hamid Al-Barznjy, et al.
Published: (2025-07-01)

The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Correlation between virological response and portal vein thrombosis in patients with chronic hepatitis B
by: Zhanghao Li, et al.
Published: (2025-07-01)

Knowledge and behaviors about hepatitis B prevention and control among carriers of hepatitis B surface antigen
by: LI Siwen, ZHOU Tiantian, ZHANG Chao, ZHANG Dan, HU Weijun
Published: (2025-03-01)

Features of occult hepatitis B diagnostics in cancer patients
by: E. A. Shevyakova, et al.
Published: (2025-03-01)

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan
by: Rafail Ibragimov, et al.
Published: (2024-12-01)

Distribution of Major Histocompatibility Complex Alleles in Cohorts of Patients with Different Levels of Post-Vaccination Antibodies against Hepatitis B
by: N. V. Vlasenko, et al.
Published: (2024-07-01)

Serum hepatitis B virus RNA in low-level viremia of chronic hepatitis B: clinical features and association with virological response
by: Yongbin Wu, et al.
Published: (2025-05-01)

Investigation of hepatitis B surface antibody levels among preschool and school-age children in Tonglu County, Zhejiang Province
by: YE Yang, et al.
Published: (2025-02-01)

Limited stability of Hepatitis B virus RNA in plasma and serum
by: Valerie Ohlendorf, et al.
Published: (2024-11-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

The dynamics of a delay model of hepatitis B virus infection with logistic hepatocyte growth
by: Steffen Eikenberry, et al.
Published: (2009-02-01)

Presence of liver fibrosis in chronic hepatitis B patients with varying serum hepatitis B virus DNA levels: Letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Jian Wang, et al.
Published: (2025-01-01)